STOCK TITAN

Intelligent Bio Solutions (INBS) Stock News

INBS Nasdaq

Welcome to our dedicated page for Intelligent Bio Solutions news (Ticker: INBS), a resource for investors and traders seeking the latest updates and insights on Intelligent Bio Solutions stock.

Intelligent Bio Solutions Inc. develops medical technology for rapid, non-invasive testing, centered on fingerprint sweat drug screening. Its updates commonly cover the Intelligent Fingerprinting Drug Screening System, Drug Screening Cartridges, DSR-Plus reader, lateral-flow test strip manufacturing, and the reader-and-consumable sales model used in workplace testing markets outside the United States.

Company news also focuses on clinical and regulatory work supporting an FDA 510(k) pathway for codeine detection, cybersecurity and validation testing tied to the system, European patent protection for fingerprint chemical analysis, manufacturing scale-up for readers and cartridges, customer deployments in the United Kingdom, and periodic revenue reports by product category.

-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
private placement
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.3%
Tags
private placement
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.4%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.64%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.24%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
134.9%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.82%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
146.89%
Tags

FAQ

What is the current stock price of Intelligent Bio Solutions (INBS)?

The current stock price of Intelligent Bio Solutions (INBS) is $2.35 as of June 10, 2026.

What is the market cap of Intelligent Bio Solutions (INBS)?

The market cap of Intelligent Bio Solutions (INBS) is approximately 5.8M.